Safety and Efficacy of Exosomes Overexpressing CD24 in Two Doses for Patients With Moderate or Severe COVID-19
Clinical trial NCT04902183 · UNKNOWN
Trial details
- NCT number
- NCT04902183
- Sponsor
- Athens Medical Society
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-09
- Primary completion
- 2021-09-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.